WHAT DID ATTENDEES AT THE NATIONAL RESTAURANT ASSOCIATION’S SHOW HAVE TO SAY ABOUT NOCOPI’S REVOLUTIONARY RUB-IT & COLOR PRODUCTS?

See Entertainment Section of the Website to learn more

INTERVIEW OF CEO MIKE FEINSTEIN CONCERNING NOCOPI'S TAMPER PROOF PRESCRIPTION PADS FEATURED IN THE PHILADELPHIA INQUIRER. FRIDAY APRIL 4, 2008

COMPANY AIMS TO STOP PRESCRIPTION FRAUD

NOCOPI TECHNOLOGIES, INC. ANNOUNCES NEW WEBSITE DETAILING TECHNOLOGIES AND PRODUCTS DEVELOPED FOR ENTERTAINMENT AND TOY PRODUCTS, SOLUTIONS AGAINST COUNTERFEITING, PRODUCT DIVERSION, AND FOR BRAND PROTECTION AND DOCUMENT SECURITY INCLUDING TAMPER RESISTANT PRESCRIPTION PADS. TUESDAY FEBRUARY 12, 2008

WEST CONSHOHOCKEN, Pa., February 12 /PRNewswire-FirstCall/ -- Nocopi Technologies, Inc., (OTC Bulletin Board: NNUP - News ) announced today that the Company now has in place a new website (see www.Nocopi.com) that presents current and future information about the Company’s Goals and Objectives, Technologies, Products, News, Contacts, and a Store Page for ordering products and obtaining licensing information to use ink technology for Entertainment and Security.

Michael A. Feinstein, M.D., Chairman and Chief Executive Officer of Nocopi, said, “we are presenting new information about the technologies and products that we have developed with our publishing partners in the large entertainment and toy products area. In addition, we explain our research and development activities to offer exciting technologies ideal for other business applications. These include developing solutions against counterfeiting, product diversion, document security, and authentication including our new Secure Rub Tamper Resistant Prescription Pads by the application of patented technologies including invisible inks, color changing inks, reactive thread and document security paper products.

Michael Minerva, of Minerva Design, located in Rochester, N.Y., said, “Our goal and purpose in working with Nocopi is to create communication tools that make their “Simple and Secure” message stand out.” Dr. Feinstein added, “We believe that we have gotten to the heart of what matters to Nocopi’s target audiences by producing a website that is compelling, communicative, and presents crisp, clear, and colorful messages that lay a foundation for Nocopi’s exciting technologies and products for entertainment, and also those for security. We enjoyed working with Minerva Design in the development of our new informative Nocopi website. We believe that we have presented the essence of what Nocopi is all about. The flashing messages that appear on our Home Page highlight Nocopi’s Vision. They are as follows:

We are committed to continue working as a team with our publishing partners to develop new and innovative products for kids of all ages. In addition, we continue to research and develop products to deal with the ever increasing problems that manufacturers, distributors, and consumers are experiencing with product counterfeiting, product diversion, and identity theft. Our progress will continue as we introduce new and improved innovations targeting this market. Our new website will always be up-to-date reflecting the present and future developments at Nocopi Technologies.”

FORWARD-LOOKING INFORMATION

The foregoing contains forward-looking information within the meaning of The Private Securities Litigation Act of 1995. Such forward-looking statements involve certain risks and uncertainties. Actual results may differ materially from such forward-looking statements (a summary of which may be found in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2006 and its Quarterly Report on Form 10-QSB for the quarter ended September 30, 2007 under the caption "Risk Factors"). The Company does not undertake to publicly update or revise its forward-looking statements even if experience or further changes make it clear that any projected results (expressed or implied) will not be realized.

Contact: Rudolph Lutterschmidt, Chief Financial Officer, Nocopi Technologies, Inc., (610) 834-9600.
Source: Nocopi Technologies, Inc.

NOCOPI TECHNOLOGIES, INC. MEETS WITH THE UNITED STATES PHARMACOPEIA (USP) GLOBAL OFFICIALS ON PHARMACEUTICAL PRODUCT COUNTERFEITING AND DIVERSION; INTRODUCES NEW TAMPER RESISTANT PRESCRIPTION PADS. THURSDAY JANUARY 10, 2008 1:04 PM ET

WEST CONSHOHOCKEN, Pa., Jan. 10 /PRNewswire-FirstCall/ -- Michael A. Feinstein, M.D., Chairman and Chief Executive Officer of Nocopi Technologies, Inc. (OTC Bulletin Board: NNUP -News) and members of his staff met recently with the USP's Executive Vice President and Chief Executive Officer Roger L. Williams, M.D., and its leadership staff representing four Continents at the Organization's Headquarters in Rockville, MD. The discussion covered worldwide efforts currently underway to combat pharmaceutical product counterfeiting and diversion, an introduction to Nocopi's Secure Rub tamper-proof prescription pads and information about Nocopi's overt and covert technologies and products.

Nocopi Technologies is a well-known company in the business of developing solutions against counterfeiting, product diversion, document security, and authentication via patented technologies (including invisible inks, color changing inks, reactive thread and document security paper products).

The USP, an independent, science-based public health organization, promotes public health by developing and disseminating quality standards and information for medicines, and disseminates this information to practitioners, pharmacists, and others who make decisions about healthcare around the world. The USP's Drug Quality and Information (USP DQI) program has established a presence in USAID-priority countries on four continents, advancing strategies to improve drug quality and the appropriate use of drugs. Recent reports indicate the availability of substandard and counterfeit drugs has reached a disturbing proportion in many low-income countries.

Both parties discussed the new federal requirements which will start to go into effect on April 1, 2008, as the result of recently enacted legislation, requiring that states not pay pharmacies for Medicaid prescriptions that do not have at least one of three characteristics designed to prevent fraud and abuse through the reproduction and/or modification of prescriptions. Those characteristics are:

Nocopi's new Tamper Resistant Prescription Pads meet all three of these requirements.

By October 1, 2008, all three anti-counterfeiting characteristics must be embedded in all Medicaid prescription orders. The Nocopi representatives demonstrated its secure prescription paper, which is marketed under the brand name Secure Rub. This economical and secure paper can be run through any offset press to print the specific information required for any doctor's office.

Nocopi participants demonstrated examples of overt and covert technologies and products designed to combat counterfeiting and diversion. Examples were provided to show how to determine where a diversion problem is occurring, and how to positively identify the real product from the knock-offs.

Dr. Feinstein said, "We believe that both overt and covert security can be blended in such a manner as to help the drug manufacturer, distributor, and pharmacist track and trace exactly where pharmaceutical products are going. Our technologies at Nocopi allow for the interruption of diversion channels, help to authenticate the product as not being counterfeit, and all at a very small cost per unit." Dr. Feinstein further added, "Nocopi is encouraged by the USP's concern about the counterfeit and diverted pharmaceutical problem. For many years a myriad of other products have been protected against such problems, and now our own health and well-being must also be."

As a follow-up to this meeting, both parties agreed to continue to exchange information about pharmaceutical counterfeiting and diversion issues. Nocopi has been requested by the USP to supply samples of its technologies and products for their consideration in current and future USP DQI program efforts.

FORWARD-LOOKING INFORMATION

The foregoing contains forward-looking information within the meaning of The Private Securities Litigation Act of 1995. Such forward-looking statements involve certain risks and uncertainties. Actual results may differ materially from such forward-looking statements (a summary of which may be found in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2006 and its Quarterly Report on Form 10-QSB for the quarter ended September 30, 2007 under the caption "Risk Factors"). The Company does not undertake to publicly update or revise its forward-looking statements even if experience or further changes make it clear that any projected results (expressed or implied) will not be realized.

Contact: Rudolph Lutterschmidt, Chief Financial Officer, Nocopi Technologies, Inc., (610) 834-9600
Source: Nocopi Technologies, Inc.

NOCOPI TECHNOLOGIES, INC., WEST CONSHOHOCKEN, PA. POSTS THIRD QUARTER AND NINE MONTHS PROFIT FOR 2007 WEDNESDAY NOVEMBER 14, 2007 9:32 AM ET

WEST CONSHOHOCKEN, Pa., Nov. 14 /PRNewswire-FirstCall/ -- Nocopi Technologies, Inc., (OTC Bulletin Board: NNUP - News) announced today that the company has posted a profit due primarily to increased licensing revenues and product sales in its Entertainment and Toy Products business. Revenues for the third quarter of 2007 were $487,000 compared to $283,000 in the third quarter of 2006, a 72% increase. For the first nine months of 2007, revenues were $1,078,100, 94% higher than revenues of $556,700 in the first nine months of 2006.

Net earnings were $299,400 and $324,300 in the third quarter and first nine months of 2007, respectively, compared to a net loss of $15,000 and $148,000 in the third quarter and first nine months of 2006, respectively, including, in 2007, income of $166,200 related to the reversal of previously accrued expenses that are no longer statutorily payable.

"As demonstrated by the growth in revenues and profit in the third quarter and first nine months of 2007, Nocopi's progress is continuing" said Michael A. Feinstein, M.D., Chairman and Chief Executive Officer of the company. "These are very exciting times for us. We are particularly pleased with the excellent working relationship we have with our publishing partners, who during this quarter successfully introduced a number of new children's activity products that incorporate our technologies. We are continuing to team up with our partners to develop new and innovative products for kids of all ages.

Nocopi has benefited from the growth in revenues since we decided in 2003 to develop specific technologies for applications in the large entertainment and toy products market. Nocopi expects more progress as we continue to introduce new and improved innovations targeting this market."

Dr. Feinstein also said, "We are continuing to research, develop, and offer technologies ideal for our other business applications which include developing solutions against counterfeiting, product diversion, document security, and authentication via patented technologies including invisible inks, color changing inks, reactive thread and document security paper products.

We have recently developed and are in the process of beginning to market a new application in response to recent legislation requiring tamper-resistant features in prescription pads used by physicians nationwide for patients enrolled in Medicare and Medicaid Programs. The requirement for tamper-resistant prescription pads goes into effect in 2008."

The current Form 10-QSB can be accessed at the U.S. Securities and Exchange Commission website http://www.sec.gov/.

FORWARD-LOOKING INFORMATION

The foregoing contains forward-looking information within the meaning of The Private Securities Litigation Act of 1995. Such forward-looking statements involve certain risks and uncertainties. Actual results may differ materially from such forward-looking statements (a summary of which may be found in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2006 and its Quarterly Report on Form 10-QSB for the quarter ended September 30, 2007 under the caption "Risk Factors"). The Company does not undertake to publicly update or revise its forward-looking statements even if experience or further changes make it clear that any projected results (expressed or implied) will not be realized.

Contact: Rudolph Lutterschmidt, Chief Financial Officer, Nocopi Technologies, Inc., (610) 834-9600
Source: Nocopi Technologies, Inc.

NOCOPI TECHNOLOGIES, INC., WEST CONSHOHOCKEN, PA, POSTS SECOND QUARTER AND SIX MONTHS PROFIT FOR 2007 AUGUST 14, 2007

West Conshohocken, PA — NoCopi Technologies, Inc., (OTC Bulletin Board: NNUP) announced today that the company posted a profit due primarily to increased licensing revenues and product sales in its Entertainment and Toy Products business. Revenues for the second quarter of 2007 were $432,600 compared to $186,800 in the second quarter of 2006, a 132% increase. For the first six months of 2007, revenues were $591,100, 116% higher than revenues of $273,700 in the first six months of 2006. Net earnings were $99,300 and $24,900 in the second quarter and first half of 2007, respectively, compared to a net loss of $52,700 and $133,000 in the second quarter and first half of 2006, respectively.

“We have made significant progress this quarter,” said Michael A. Feinstein, M.D., Chairman and Chief Executive Officer of the company. “In particular, we are excited about the progress we have made with our publishing partners, Giddy Up and Color Loco of Ann Arbor, Michigan, two major established and leading children’s books publishers with proven track records of innovation and impressive distribution; and Elmer’s Products, Inc., of Columbus, Ohio, an industry leader in adhesives, arts and crafts and educational products. We are continually working together with our partners in a united effort to develop new and innovative technologies.

NoCopi has benefited from the growth in revenues since we decided in 2003 to develop specialty reactive inks for applications in the large Entertainment and Toy Products market. Nocopi expects more progress as we continue to introduce new and improved technologies targeting this market.”

Dr. Feinstein also said, “We will continue to offer technologies ideal for our other business applications which includes developing solutions against counterfeiting, product diversion, document security, and authentication via patented technologies including invisible inks, color changing inks, reactive thread and document security paper products.”

FORWARD-LOOKING INFORMATION

The foregoing contains forward-looking information within the meaning of The Private Securities Litigation Act of 1995. Such forward-looking statements involve certain risks and uncertainties. Actual results may differ materially from such forward-looking statements (a summary of which may be found in the Company’s Annual Report on Form10-KSB for the year ended December 31, 2006 and its Quarterly Report on Form 10-QSB for the quarter ended June 30, 2007 under the caption “Risk Factors”). The Company does not undertake to publicly update or revise its forward-looking statements even if experience or further changes make it clear that any projected results (expressed or implied) will not be realized.

Source: Rudolph Lutterschmidt, Chief Financial Officer, NoCopi Technologies, Inc., (610) 834-9600